SIM-0508

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameSIM-0508
Drug Alias NameSIM-0508
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA polymerase theta inhibitors
TargetsDNA polymerase theta
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHainan Xiansheng Re Ming Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHainan Xiansheng Re Ming Pharmaceutical Co LtdShanghai Xiansheng Zaiming Pharmaceutical Biotechnology Co LtdJiangsu Simcere Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A